These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21520358)

  • 1. Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients.
    Raki M; Sarkioja M; Escutenaire S; Kangasniemi L; Haavisto E; Kanerva A; Cerullo V; Joensuu T; Oksanen M; Pesonen S; Hemminki A
    J Gene Med; 2011 May; 13(5):253-61. PubMed ID: 21520358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.
    Särkioja M; Pesonen S; Raki M; Hakkarainen T; Salo J; Ahonen MT; Kanerva A; Hemminki A
    Gene Ther; 2008 Jun; 15(12):921-9. PubMed ID: 18401431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
    Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
    Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera.
    Yu B; Dong J; Wang C; Zhan Y; Zhang H; Wu J; Kong W; Yu X
    Virology; 2013 Mar; 437(2):118-23. PubMed ID: 23351390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conditionally replicating adenovirus with strict selectivity in killing cells expressing epidermal growth factor receptor.
    Carette JE; Graat HC; Schagen FH; Mastenbroek DC; Rots MG; Haisma HJ; Groothuis GM; Schaap GR; Bras J; Kaspers GJ; Wuisman PI; Gerritsen WR; van Beusechem VW
    Virology; 2007 Apr; 361(1):56-67. PubMed ID: 17184803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver.
    Kuriyama S; Tominaga K; Kikukawa M; Tsujimoto T; Nakatani T; Tsujinoue H; Okuda H; Nagao S; Mitoro A; Yoshiji H; Fukui H
    Gene Ther; 1999 May; 6(5):749-57. PubMed ID: 10505097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues.
    Koski A; Bramante S; Kipar A; Oksanen M; Juhila J; Vassilev L; Joensuu T; Kanerva A; Hemminki A
    Mol Ther; 2015 Oct; 23(10):1641-52. PubMed ID: 26156245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.
    Myhre S; Henning P; Granio O; Tylö AS; Nygren PA; Olofsson S; Boulanger P; Lindholm L; Hong SS
    Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery.
    Rojas LA; Condezo GN; Moreno R; Fajardo CA; Arias-Badia M; San Martín C; Alemany R
    J Control Release; 2016 Sep; 237():78-88. PubMed ID: 27388756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
    Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.
    Bradley RR; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
    J Virol; 2012 Jan; 86(1):625-9. PubMed ID: 22072776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer.
    Koski A; Raki M; Nokisalmi P; Liikanen I; Kangasniemi L; Joensuu T; Kanerva A; Pesonen S; Alemany R; Hemminki A
    Mol Ther; 2012 Jan; 20(1):221-9. PubMed ID: 22044933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimeric knob protein specifically distinguishes neutralizing antibodies to different human adenovirus species: potential application for adenovirus seroepidemiology.
    Yu B; Dong J; Wang C; Wang Z; Gao L; Zhang H; Wu J; Kong W; Yu X
    J Gen Virol; 2014 Jul; 95(Pt 7):1564-1573. PubMed ID: 24764358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of transcriptionally regulated oncolytic adenoviruses.
    Ko D; Hawkins L; Yu DC
    Oncogene; 2005 Nov; 24(52):7763-74. PubMed ID: 16299536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors.
    Zepeda M; Wilson JM
    Gene Ther; 1996 Nov; 3(11):973-9. PubMed ID: 8940637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of adenoviral vectors through a bispecific single-chain antibody.
    Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
    Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a selective biopharmaceutical from Herpes simplex virus type 1 glycoproteins E and I for blocking antibody mediated neutralization of oncolytic viruses.
    Bucurescu S
    Acta Pharm; 2010 Dec; 60(4):407-13. PubMed ID: 21169133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic adenoviruses - selective retargeting to tumor cells.
    Mathis JM; Stoff-Khalili MA; Curiel DT
    Oncogene; 2005 Nov; 24(52):7775-91. PubMed ID: 16299537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic (replication-competent) adenoviruses as anticancer agents.
    Toth K; Dhar D; Wold WS
    Expert Opin Biol Ther; 2010 Mar; 10(3):353-68. PubMed ID: 20132057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens.
    Klein SR; Jiang H; Hossain MB; Fan X; Gumin J; Dong A; Alonso MM; Gomez-Manzano C; Fueyo J
    PLoS One; 2016; 11(4):e0153814. PubMed ID: 27093696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.